12 January 2021
The Targeted Translation Research Accelerator (TTRA) initiative, a Medical Research Future Fund initiative delivered by MTPConnect, is rolling out a $38 million funding opportunity to improve the prevention, diagnosis, management and treatment of diabetes, cardiovascular disease and their related complications in Australia.
To stimulate collaboration across industry, research and clinical organisations, we’re allocating $20 million to support the establishment of two new Research Centres; one focused on diabetes-associated complications and the other on cardiovascular disease-associated complications and each funded for up to $10 million over four years.
Applications are now open for Expressions of Interest for these two new Research Centres, and close at 16:00 AEDT on 15 March 2021.
We invite you to attend a TTRA Research Centres Information Session webinar on 20 January 2021 at 3:30-4:30pm AEDT, to learn more about this funding opportunity.
MTPConnect Managing Director & CEO Dr Dan Grant and TTRA Expert Advisory Board Chair Prof Ian Frazer AC FRS will discuss the Research Centres opportunity.
Lauren Kelly, MTPConnect Senior Director for the TTRA program and Dr Mana Liao, MTPConnect Director for the TTRA program, will outline the priority areas, submission process and provide relevant information about preparing an application.
Register for the TTRA Information Session today.